This contract expires in 339 days (Sep 28, 2027).
DELOITTE CONSULTING LLP - FDA BUDGET EXECUTION AND CONTROL SUPPORT
Key Details
Description
FDA BUDGET EXECUTION AND CONTROL SUPPORT
Context & Analysis
On Dec 8, 2022, Department of Health and Human Services obligated $24,329,855.11 to DELOITTE CONSULTING LLP for fda budget execution and control support. The award is classified under NAICS 541611 — ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES. Competition extent: full and open competition. Performance is located in BELTSVILLE, MD. The contract is scheduled through Sep 28, 2027 — approximately 11 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541611 — related awards are listed below.
Market context
- Recompete outlook
- Ends Sep 28, 2027, in 11 months. Recompete signal as of Oct 20, 2026: 49/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competed. 81% of 899 awards in this market (Department of Health and Human Services awards in NAICS 541611 over the last 3 years) were competed; median 3 offers.
- Award size
- At $24.3M, this award is larger than 19 in 20 of the 1624 priced Department of Health and Human Services awards in NAICS 541611 over the last 3 years (median $702K).
- Incumbent at this agency
- DELOITTE CONSULTING LLP has 428 other awards from Department of Health and Human Services, totalling $6.1B, 2013–2026.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 541611 over the last 3 years.
- GENERAL DYNAMICS CORP — 3 awards, $411.8M
- MAXIMUS INC — 7 awards, $358.4M
- RESEARCH TRIANGLE INSTITUTE — 46 awards, $326.3M
- BOOZ ALLEN HAMILTON HOLDING CORPORATION — 34 awards, $308.1M
- VERITAS CAPITAL FUND MANAGEMENT, L.L.C. — 25 awards, $228.6M
Computed from USAspending award data on Oct 20, 2026.
Contractor Information
Subcontractors on this Prime(2 disclosed)
First-tier subawards from USASpending’s FSRS reporting. Sub-recipient names are often partially disclosed or redacted; amounts reflect the sub portion only.
| Subcontractor | Amount |
|---|---|
| Not disclosed Jun 12, 2026 | $788,938.2 |
| Not disclosed Nov 14, 2025 | $196,200 |
Related Federal Investment
Similar Awards
IGF::OT::IGF-PPHF-2013-ELIGIBILITY SUPPORT
SERCO INC
$1.2B
IGF::OT::IGF FOR OTHER FUNCTIONS
HIGHPOINT DIGITAL, INC.
$839.9M
IGF::OT::IGF CCIIO ENROLLMENT RESOLUTION AND RECONCILIATION, FORM 1095-A DATA REPORTING TASK ORDER
COGNOSANTE, LLC
$315.5M
IGF::OT::IGF ELIGIBILITY APPEALS OPERATIONS SUPPORT
MAXIMUS FEDERAL SERVICES, INC.
$286.9M
IGF::OT::IGF THE CERT PROGRAM CALCULATES BI-ANNUAL IMPROPER PAYMENT RATES BASED ON THE RESULTS OF THE REVIEWS CONDUCTED. THESE RATES INCLUDE AN OVERALL NATIONAL MEDICARE FFS IMPROPER PAYMENT RATE AND IMPROPER PAYMENT RATES FOR EACH CLAIM TYPE [PART A INPATIENT HOSPITAL PROSPECTIVE PAYMENT SYSTEM (PPS); PART A EXCLUDING INPATIENT HOSPITAL PPS; PART B; AND DURABLE MEDICAL EQUIPMENT, PROSTHETICS, ORTHOTICS, AND SUPPLIES (DMEPOS)]. THE CERT PROGRAM ENSURES A STATISTICALLY VALID RANDOM SAMPLE; THEREFORE, THE IMPROPER PAYMENT RATE CALCULATED FROM THIS SAMPLE IS CONSIDERED TO BE REFLECTIVE OF ALL OF CLAIMS PROCESSED BY MEDICARE FFS PROGRAM DURING THE REPORT PERIOD. CMS ALSO USES THE CERT PROGRAM TO PERFORM SPECIAL STUDIES AND SUPPLEMENTAL MEASUREMENTS TO DETERMINE THE IMPROPER PAYMENT RATES OF PARTICULAR CLAIM TYPES. CALCULATIONS OF THESE RATES FACILITATE CMS ABILITY TO TAKE APPROPRIATE CORRECTIVE ACTIONS TO REDUCE IMPROPER PAYMENTS.
EMPOWER AI, INC.
$230.2M
Stay Updated
Get notified about new opportunities matching your interests.